Our findings revealed that the analysis of APOE, PSEN1, PICALM, ABCB7 and SNCA mRNA levels can be used to differentiate between PD, AD, and VaD/mixed dementia, and may serve as potential biomarkers for the early detection of these NDDs. This evidence concerns the gene SNCA and Alzheimer disease.